Sintx Technologies (NASDAQ:SINT) Full Year 2023 Results

Key Financial Results

• Revenue: US$2.63m (up 68% from FY 2022).
• Net loss: US$8.29m (loss narrowed by 50% from FY 2022).
• US$2.22 loss per share (improved from US$54.67 loss in FY 2022).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Sintx Technologies Earnings Insights

Looking ahead, revenue is expected to decline by 6.1% p.a. on average during the next 2 years, while revenues in the Medical Equipment industry in the US are expected to grow by 7.9%.

Performance of the American Medical Equipment industry.

The company's shares are down 46% from a week ago.

Risk Analysis

We should say that we've discovered 6 warning signs for Sintx Technologies (4 are potentially serious!) that you should be aware of before investing here.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.